Ready to revolutionize healthcare, making it faster and more accessible than ever before?
How we started:
Founded in 2013 by Dwayne D’Souza, HeliosX was built on a simple but powerful idea: healthcare should be easier to access, faster to receive, and centred around the individual. From day one, we’ve grown without external funding; scaling profitably through technology, disciplined execution, and deep medical expertise. What started as a challenger idea has become one of the most significant healthcare platforms operating globally today.
Where we are now:
We’ve earned the trust of millions of people worldwide through category-leading products and well-known brands, including MedExpress, Dermatica, ZipHealth, RocketRX, and Levity. A key driver of our success is vertical integration; we operate our own manufacturing and proprietary products, led by in-house medical teams, researchers, and pharmacists at the top of their fields.
In 2025, HeliosX treated more than 1.7 million patients globally and reached £781m in revenue, representing +337% year-on-year growth and cementing our position as the clear market leader in the UK. That growth translates into real-world outcomes: our weight-loss treatments helped patients lose 8.5 million kilograms of excess weight in 2025 alone, contributing to an estimated 1,300 fewer cardiac events. This is growth with measurable, life-changing impact at scale.
Today, we operate across four international markets, with successful launches in Germany and Canada and continued expansion in the US. We were also recently recognised in the Sunday Times Top 100 fastest-growing tech companies, further validation of both our momentum and our ambition.
Where we’re going:
2026 is a step-change year. Our ambition is to reach £1.6bn in revenue, expand from four to eight global markets and significantly broaden our condition and treatment portfolio. Over the coming years, you’ll help shape HeliosX into a truly world-leading healthcare partner; one that combines scale, speed, and clinical rigour to redefine how personalised care is delivered. Joining HeliosX now means building systems, teams, and products that will define the next decade of digital healthcare, and doing work that genuinely improves lives, at global scale.
There’s never been a more exciting time to join HeliosX. Come be a part of making our dream of easier and faster healthcare a reality!
About the role:
As an FP&A Analyst, you’ll act as a key finance partner to Operations—owning critical forecasting processes, improving reporting accuracy, and delivering insights that drive performance.
You’ll work across multiple cost areas and geographies, helping the business understand its cost base, evaluate opportunities, and optimise efficiency as we scale.
What you'll be doing
Preparation of timely and reliable weekly trade reports for senior stakeholders across the business on performance across sales, margin and other KPIs. Focusing on actionable insights, analysis and commentary.
Preparation of monthly board reporting packs, working cross functionally to bring together performance metrics from across the business.Ownership of operating costs forecasting and month end reconciliation.
Maintenance of monthly trackers for review with budget holders.
Conducting variance analysis to understand deviations from forecast. Working with the accounting team to validate month end postings. Communicate risks and ops to senior leadership.
Who you are:
Why work with us?
At HeliosX, we want to improve healthcare for everyone, and to do this we need a team of brilliant people who share that ambition. We are currently a diverse team of engineers, scientists, clinical researchers, physicians, pharmacists, marketeers, and customer care specialists committed to our mission - but we need more talented folks to join us, if we want to achieve our global ambitions!
Aside from working with our all-star team, here are the other benefits of coming on board:
#LI-Senior #LI-Hybrid